NewcelX Ltd.

NCEL | NASDAQ

Price Alert Chart Builder DCF Calculator

$3.04

+$0.07 (+2.36%)

At close: Sep 22, 2026, 4:00 PM ET

$2.93

-$0.11 (-3.62%)

After-hours: Sep 22, 2026, 4:04 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+2.36%

(1D)

Rating

Updated: Sep 19, 2026

16.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $1.37M

1D Range

2.90 3.37

52W Range

1.83 24.60

Valuation (TTM)

PE 9

PB 0.22

EV/EBITDA -0.27

Valuation (NTM)

Forward PE 0.00

Forward PEG -0.18

Price Target N/A

Cash Flow

FCF Yield -215.0%

SBC Adj. FCF Yield -215.1%

SBC Impact 0.0%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 120.0% | -6.3%

FCF 3Y | 5Y 86.8% | 37.3%

Returns

ROA 14.9%

ROE 21.8%

ROIC -103.6%

Financial Health

Net Cash

$318K

Current Ratio 0.32

Interest Coverage -1.21

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

NewcelX Ltd., a biotechnology firm established in 2008 and based in Zurich, Switzerland, is dedicated to advancing groundbreaking therapeutic solutions. The company's focus lies in developing innovati...

Sector Healthcare

Industry Biotechnology

Employees 11

IPO Date Oct 23, 2025

Website newcelx.net

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.